摘要
随着基本药物目录的颁布,基本药物制度的实施势必会对我国医药企业产生巨大的影响。通过对基本药物制度中相关内容的分析,揭示基本药物制度对于不同类型企业的不同影响。从行业上看,药品总用量将会上升,原有的药品市场竞争格局将发生改变。从企业层面看,进入药品目录的企业对药品价格更加关注,而没有进入目录的企业将受到很大的冲击。最后从医药企业的角度提出了应对措施。
Essential medicines system has been publicized. Implementation of the national essential medicines system is to provide a significant impact on pharmaceutical enterprises in China. This paper attempts to address the context and content of essential medicines system in order to reveal the effects to different types of pharmaceutical enterprises. From the prospective of whole phareeutical industry, the drug utilization will expand enormously and the market competition will be changed largely. From the prospective of pharmaceutical enterprises, those whose products have entered into the essential medicine list will pay more attention to the drug price, and those whose products have not entered into the list will be influnced enormously. Finally, it provides a responsive strategy for pharmaceutical enterprises to cope with the system in terms of enterprises＇ objective.
出处
《中国卫生政策研究》
2010年第1期58-60,共3页
Chinese Journal of Health Policy
关键词
基本药物制度
医药企业
影响
Essential medicines system
Pharmaceutical enterprise
Impact
